METTL14 and breast carcinoma: We further combined the data of TIMER, cBioPortal, Kaplan–Meier plotter and other databases to analyze the prognostic value of METTL14 and ZC3H13 in breast cancer, their co-expressed genes and related signaling pathways, as well as the relationship between their expression levels and infiltrating immune cells in tumor tissues.